Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

The Lancet Infectious Diseases - Tập 17 - Trang 153-163 - 2017
Hajo Grundmann1,2, Corinna Glasner2,3, Barbara Albiger4, David M Aanensen3,5, Chris T Tomlinson6, Arjana Tambić Andrasević7, Rafael Cantón8,9, Yehuda Carmeli10, Alexander W Friedrich2, Christian G Giske11,12, Youri Glupczynski13,14, Marek Gniadkowski15, David M Livermore16,17, Patrice Nordmann18,19, Laurent Poirel18,19, Gian M Rossolini20,21, Harald Seifert22,23, Alkiviadis Vatopoulos24, Timothy Walsh25, Neil Woodford16
1Department of Infection Prevention and Hospital Hygiene, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Netherlands
3The Centre for Genomic Pathogen Surveillance, Wellcome Trust Genome Campus, Cambridgeshire, UK
4European Centre for Disease Prevention and Control, Stockholm, Sweden
5Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK
6Department of Surgery and Cancer, South Kensington Campus, Imperial College London, London, UK
7Department of Clinical Microbiology, University Hospital for Infectious Diseases, Zagreb, Croatia
8Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
9Unidad de Resistencia a Antibióticos y Virulencia Bacteriana asociada al Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
10Division of Epidemiology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel
11Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
12Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
13Department of Clinical Microbiology, CHU Dinant-Godinne UCL, Namur, Université Catholique de Louvain, Yvoir, Belgium
14National Reference Laboratory for Antibiotic Resistance Monitoring in Gram-negative Bacteria, CHU Dinant-Godinne UCL, Namur, Université Catholique de Louvain, Yvoir, Belgium
15Department of Molecular Microbiology, National Medicines Institute, Warsaw, Poland
16Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, Reference Microbiology Services, Public Health England, London, UK
17Norwich Medical School, University of East Anglia, Norwich, UK
18INSERM U914 (Emerging Resistance to Antibiotics), Associated National Reference Center for Antibiotic Resistance, Faculté de Médecine et Université Paris-Sud, K Bicêtre, France
19Medical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Switzerland
20Dipartimento di Biotecnologie Mediche, Università di Siena, Siena, Italy
21SOD Microbiologia e Virologia, Azienda Ospedaliera-Universitaria Careggi, Fondazione Don Carlo Gnocchi, Firenze, Italy
22Institute for Medical Microbiology, Immunology and Hygiene, Cologne University, Cologne, Germany
23German Center for Infection Research (DZIF), Braunschweig, Germany
24Department of Microbiology, National School of Public Health, Athens, Greece
25Section of Medical Microbiology IIB, School of Medical Sciences, Cardiff University, Heath Park Hospital, Cardiff, UK

Tài liệu tham khảo

Nordmann, 2011, Global spread of carbapenemase-producing Enterobacteriaceae, Emerg Infect Dis, 17, 1791, 10.3201/eid1710.110655 Monaco, 2014, Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014, Euro Surveill, 19, 10.2807/1560-7917.ES2014.19.42.20939 Livermore, 2015, In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase, Antimicrob Agents Chemother, 59, 5324, 10.1128/AAC.00678-15 Alm, 2015, Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3, J Antimicrob Chemother, 70, 1420, 10.1093/jac/dku568 Glasner, 2013, Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013, Euro Surveill, 18, 10.2807/1560-7917.ES2013.18.28.20525 Nordmann, 2012, Rapid Detection of Carbapenemase-producing Enterobacteriaceae, Emerg Infect Dis, 18, 1503, 10.3201/eid1809.120355 Giakoupi, 2009, KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone, Euro Surveill, 14 Schwaber, 2011, Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention, Clin Infect Dis, 52, 848, 10.1093/cid/cir025 Hasan, 2014, Dissemination of blaVIM in Greece at the peak of the epidemic of 2005–2006: clonal expansion of Klebsiella pneumoniae clonal complex 147, Clin Microbiol Infect, 20, 34, 10.1111/1469-0691.12187 Samra, 2007, Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel, Int J Antimicrob Agents, 30, 525, 10.1016/j.ijantimicag.2007.07.024 Sisto, 2012, Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012, Euro Surveill, 17, 10.2807/ese.17.33.20247-en Oteo, 2015, Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem, Antimicrob Agents Chemother, 59, 3406, 10.1128/AAC.00086-15 Albiger, 2015, Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015, Euro Surveill, 20, 30062, 10.2807/1560-7917.ES.2015.20.45.30062 Izdebski, 2015, MLST reveals potentially high-risk international clones of Enterobacter cloacae, J Antimicrob Chemother, 70, 48, 10.1093/jac/dku359 Giakkoupi, 2003, VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals, J Clin Microbiol, 41, 3893, 10.1128/JCM.41.8.3893-3896.2003 Nordmann, 2011, The emerging NDM carbapenemases, Trends Microbiol, 19, 588, 10.1016/j.tim.2011.09.005 Lixandru, 2015, Carbapenemase-producing Klebsiella pneumoniae in Romania: a six-month survey, PLoS One, 10, e0143214, 10.1371/journal.pone.0143214 Meletis, 2014, Carbapenemase reports from the Balkans: a systematic review, Infez Med, 22, 85 Magiorakos, 2014, Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance, Clin Microbiol Infect, 18, 268, 10.1111/j.1469-0691.2011.03570.x Lee, 2012, Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports, Ann Clin Microbiol Antimicrob, 11, 1, 10.1186/1476-0711-11-32 Tumbarello, 2012, Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K pneumoniae: importance of combination therapy, Clin Infect Dis, 55, 943, 10.1093/cid/cis588
Thông tin
Thông tin xuất bản

The Lancet Infectious Diseases

Tập 17

153-163

Thông tin tác giả